Eric J Ip, PHARMD
Pharmacist · Mountain View
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Eric J Ip’s office at (650) 903-2610 to ask if they take your plan before you enroll.
California Medical Board record
Licence G58424 · Current
Licensed to practise in California · since 1986 · expires 2028-04-30 · University of Southern California Keck School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$125,555
Pharmacies billed $125,555 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,236) in 2024. At or below the middle of the specialty; the typical pharmacist clinician is at 0%.
892 generic and 261 brand-name prescriptions · $125,555 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ozempic | 78 | $57,721 | $740 |
| Jardiance | 55 | $31,155 | $566 |
| Humulin N | 40 | $7,176 | $179 |
| Insulin Glargine-Yfgn | 40 | $4,704 | $118 |
| Atorvastatin | 200 | $2,441 | $12 |
See all 20 drugs
| Ozempic | 78 | $57,721 | $740 |
| Jardiance | 55 | $31,155 | $566 |
| Humulin N | 40 | $7,176 | $179 |
| Insulin Glargine-Yfgn | 40 | $4,704 | $118 |
| Atorvastatin | 200 | $2,441 | $12 |
| Humulin 70-30 | 11 | $1,541 | $140 |
| Glipizide | 106 | $1,362 | $13 |
| Metformin Hcl Er | 136 | $1,332 | $10 |
| Metformin | 88 | $1,130 | $13 |
| Glipizide Er | 30 | $1,122 | $37 |
| Veo Insulin | 43 | $975 | $23 |
| Lisinopril | 56 | $706 | $13 |
| Simvastatin | 48 | $557 | $12 |
| Amlodipine Besylate | 42 | $514 | $12 |
| Losartan | 39 | $502 | $13 |
| Hydrochlorothiazide | 36 | $437 | $12 |
| Atenolol | 27 | $336 | $12 |
| Lisinopril-Hydrochlorothiazide | 20 | $291 | $15 |
| Rosuvastatin | 15 | $178 | $12 |
| Pioglitazone | 11 | $148 | $13 |
Year by year
| 2024 | 1,236 | 164 | 0% (0) | 21% | $125,555 |
| 2023 | 1,239 | 153 | 0% (0) | 18% | $130,743 |
| 2022 | 1,037 | 151 | 0% (0) | 17% | $78,753 |
| 2021 | 981 | 167 | 0% (0) | 14% | $61,904 |
| 2020 | 1,004 | 161 | 0% (0) | 10% | $50,188 |
| 2019 | 1,285 | 182 | 0% (0) | 11% | $48,075 |
| 2018 | 1,131 | 162 | 0% (0) | 26% | $47,118 |
| 2017 | 616 | 115 | 0% (0) | 37% | $44,071 |
| 2016 | 437 | 95 | 0% (0) | 41% | $42,464 |
| 2015 | 359 | 75 | 0% (0) | 42% | $24,857 |
| 2014 | 358 | 79 | 0% (0) | 40% | $25,805 |
| 2013 | 283 | 71 | 0% (0) | 38% | $18,812 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Jardiance | 63 | $48,187 | $765 |
| Ozempic | 30 | $37,881 | $1,263 |
| Humulin N | 52 | $10,614 | $204 |
| Humulin N Kwikpen | 14 | $5,135 | $367 |
| Lantus | 25 | $4,514 | $181 |
| Atorvastatin | 176 | $2,409 | $14 |
| Insulin Glargine-Yfgn | 16 | $1,718 | $107 |
| Glipizide | 136 | $1,693 | $12 |
| Metformin Hcl Er | 146 | $1,410 | $10 |
| Metformin | 90 | $1,202 | $13 |
| Glipizide Er | 30 | $1,195 | $40 |
| Veo Insulin | 40 | $909 | $23 |
| Simvastatin | 65 | $744 | $11 |
| Lisinopril | 59 | $686 | $12 |
| Losartan | 47 | $629 | $13 |
| Hydrochlorothiazide | 35 | $426 | $12 |
| Amlodipine Besylate | 30 | $364 | $12 |
| Veo Insulin | 12 | $294 | $24 |
| Atenolol | 23 | $293 | $13 |
| Pioglitazone | 12 | $250 | $21 |
| Rosuvastatin | 19 | $222 | $12 |
| Lisinopril-Hydrochlorothiazide | 14 | $217 | $15 |
| Veo Insulin | 11 | $195 | $18 |
2022: 19 drugs
| Jardiance | 51 | $34,877 | $684 |
| Lantus | 35 | $9,487 | $271 |
| Humulin N | 44 | $8,163 | $186 |
| Humulin N Kwikpen | 21 | $4,756 | $226 |
| Atorvastatin | 172 | $2,286 | $13 |
| Glipizide | 106 | $1,244 | $12 |
| Metformin Hcl Er | 117 | $1,161 | $10 |
| Metformin | 82 | $1,098 | $13 |
| Glipizide Er | 23 | $1,096 | $48 |
| Lisinopril | 58 | $677 | $12 |
| Simvastatin | 57 | $669 | $12 |
| Veo Insulin | 30 | $575 | $19 |
| Losartan | 36 | $460 | $13 |
| Hydrochlorothiazide | 24 | $300 | $13 |
| Pioglitazone | 13 | $298 | $23 |
| Amlodipine Besylate | 25 | $286 | $11 |
| Lisinopril-Hydrochlorothiazide | 17 | $252 | $15 |
| Metoprolol | 13 | $168 | $13 |
| Atenolol | 13 | $162 | $12 |
2021: 20 drugs
| Jardiance | 29 | $19,786 | $682 |
| Lantus | 22 | $11,623 | $528 |
| Humulin N | 53 | $10,352 | $195 |
| Humulin 70-30 | 13 | $2,539 | $195 |
| Atorvastatin | 168 | $2,322 | $14 |
| Glipizide Er | 16 | $1,250 | $78 |
| Metformin Hcl Er | 117 | $1,221 | $10 |
| Metformin | 88 | $1,151 | $13 |
| Glipizide | 94 | $1,126 | $12 |
| Simvastatin | 55 | $642 | $12 |
| Lisinopril | 52 | $607 | $12 |
| Losartan | 35 | $480 | $14 |
| Veo Insulin | 24 | $412 | $17 |
| Lisinopril-Hydrochlorothiazide | 20 | $293 | $15 |
| Veo Insulin | 15 | $285 | $19 |
| Amlodipine Besylate | 21 | $245 | $12 |
| Veo Insulin | 13 | $237 | $18 |
| Atenolol | 18 | $210 | $12 |
| Hydrochlorothiazide | 17 | $202 | $12 |
| Pioglitazone | 11 | $200 | $18 |
2020: 18 drugs
| Lantus | 16 | $21,556 | $1,347 |
| Humulin N | 44 | $6,821 | $155 |
| Humulin 70-30 | 16 | $3,154 | $197 |
| Atorvastatin | 181 | $2,905 | $16 |
| Metformin | 105 | $1,438 | $14 |
| Glipizide Er | 18 | $1,389 | $77 |
| Glipizide | 96 | $1,180 | $12 |
| Metformin Hcl Er | 111 | $1,166 | $11 |
| Lisinopril | 62 | $758 | $12 |
| Losartan | 50 | $641 | $13 |
| Simvastatin | 52 | $602 | $12 |
| Lisinopril-Hydrochlorothiazide | 25 | $361 | $14 |
| Veo Insulin | 26 | $356 | $14 |
| Atenolol | 26 | $336 | $13 |
| Amlodipine Besylate | 28 | $326 | $12 |
| Hydrochlorothiazide | 19 | $225 | $12 |
| Veo Insulin | 12 | $177 | $15 |
| Lovastatin | 13 | $165 | $13 |
2019: 21 drugs
| Lantus | 14 | $12,276 | $877 |
| Humulin N | 55 | $8,264 | $150 |
| Atorvastatin | 222 | $5,356 | $24 |
| Metformin | 119 | $1,634 | $14 |
| Metformin Hcl Er | 121 | $1,346 | $11 |
| Glipizide | 105 | $1,340 | $13 |
| Lisinopril | 110 | $1,329 | $12 |
| Glipizide Er | 12 | $946 | $79 |
| Simvastatin | 71 | $838 | $12 |
| Losartan | 61 | $779 | $13 |
| Atenolol | 46 | $647 | $14 |
| Amlodipine Besylate | 57 | $612 | $11 |
| Pravastatin | 16 | $541 | $34 |
| Lisinopril-Hydrochlorothiazide | 30 | $440 | $15 |
| Veo Insulin | 31 | $421 | $14 |
| Metoprolol | 13 | $383 | $29 |
| Lovastatin | 26 | $337 | $13 |
| Metoprolol | 27 | $308 | $11 |
| Veo Insulin | 13 | $307 | $24 |
| Hydrochlorothiazide | 23 | $248 | $11 |
| Pioglitazone | 11 | $205 | $19 |
2018: 18 drugs
| Lantus | 18 | $14,466 | $804 |
| Humulin N | 54 | $8,788 | $163 |
| Atorvastatin | 194 | $5,145 | $27 |
| Metformin Hcl Er | 102 | $1,576 | $15 |
| Glipizide | 98 | $1,443 | $15 |
| Metformin | 94 | $1,287 | $14 |
| Lisinopril | 88 | $1,063 | $12 |
| Losartan | 57 | $1,010 | $18 |
| Simvastatin | 71 | $827 | $12 |
| Atenolol | 48 | $684 | $14 |
| Veo Insulin | 38 | $532 | $14 |
| Amlodipine Besylate | 47 | $370 | $8 |
| Pravastatin | 11 | $356 | $32 |
| Lovastatin | 26 | $340 | $13 |
| Metoprolol | 24 | $300 | $12 |
| Hydrochlorothiazide | 27 | $288 | $11 |
| Lisinopril-Hydrochlorothiazide | 19 | $274 | $14 |
| Pioglitazone | 11 | $234 | $21 |
2017: 14 drugs
| Lantus | 20 | $13,830 | $692 |
| Humulin N | 59 | $9,116 | $155 |
| Atorvastatin | 108 | $2,956 | $27 |
| Glipizide | 59 | $912 | $15 |
| Metformin Hcl Er | 55 | $888 | $16 |
| Losartan | 23 | $602 | $26 |
| Metformin | 42 | $554 | $13 |
| Insulin | 30 | $500 | $17 |
| Simvastatin | 39 | $496 | $13 |
| Insulin | 14 | $468 | $33 |
| Lisinopril | 26 | $309 | $12 |
| Atenolol | 13 | $198 | $15 |
| Lovastatin | 11 | $155 | $14 |
| Amlodipine Besylate | 15 | $112 | $7 |
2016: 13 drugs
| Lantus | 12 | $11,785 | $982 |
| Humulin N | 54 | $7,312 | $135 |
| Atorvastatin | 75 | $2,116 | $28 |
| Humulin R | 11 | $1,230 | $112 |
| Bd Ultra-Fine Pen Needle | 16 | $855 | $53 |
| Simvastatin | 36 | $684 | $19 |
| Glipizide | 39 | $659 | $17 |
| Metformin Hcl Er | 37 | $571 | $15 |
| Insulin | 26 | $508 | $20 |
| Insulin | 15 | $460 | $31 |
| Losartan | 13 | $440 | $34 |
| Metformin | 24 | $274 | $11 |
| Lisinopril | 15 | $175 | $12 |
2015: 10 drugs
| Humulin N | 46 | $4,720 | $103 |
| Atorvastatin | 66 | $1,716 | $26 |
| Insulin | 37 | $1,334 | $36 |
| Bd Ultra-Fine Pen Needle | 12 | $787 | $66 |
| Insulin | 15 | $666 | $44 |
| Simvastatin | 36 | $659 | $18 |
| Glipizide | 27 | $544 | $20 |
| Metformin Hcl Er | 29 | $444 | $15 |
| Metformin | 13 | $158 | $12 |
| Lisinopril | 11 | $142 | $13 |
2014: 8 drugs
| Humulin N | 45 | $4,418 | $98 |
| Atorvastatin | 51 | $1,483 | $29 |
| Insulin | 36 | $913 | $25 |
| Simvastatin | 47 | $830 | $18 |
| Glipizide | 31 | $622 | $20 |
| Metformin Hcl Er | 30 | $531 | $18 |
| Insulin | 12 | $377 | $31 |
| Lisinopril | 14 | $163 | $12 |
2013: 8 drugs
| Humulin N | 41 | $3,720 | $91 |
| Humulin R | 14 | $1,042 | $74 |
| Atorvastatin | 29 | $1,018 | $35 |
| Simvastatin | 37 | $813 | $22 |
| Insulin | 31 | $675 | $22 |
| Glipizide | 23 | $522 | $23 |
| Metformin Hcl Er | 18 | $274 | $15 |
| Metformin | 21 | $242 | $12 |
Professional record
- NPI
- 1457550949
- Licence
- CA 58424California G58424: Current · expires 2028-04-30
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 183500000X (183500000X)
- Mailing address
- 555 Castro St, Mountain View, CA, 94041
- NPI first listed
- 2007-07-13
- NPI last updated
- 2007-07-13
This is when the NPI record was last certified, not a medical board exam.